Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

• Autors principals: Shinya Takasaki (Autor), Hisanobu Adachi (Autor), Yoshihide Kawasaki (Autor), Masafumi Kikuchi (Autor), Akihiro Ito (Autor), Nariyasu Mano (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Pazopanib is an orally available multi-tyrosine kinase inhibitor and has been used to treat renal cell carcinoma (RCC). Here, we report the case of a patient with RCC with an increased prothrombin time-international normalized ratio (PT-INR) due to pazopanib therapy. In addition, we have reported th...